<p>泰尼特保健（NYSE:THC - 获取免费报告）在周四发布给客户和投资者的研究报告中，华尔街分析师将其目标价格从 238.00 美元上调至 252.00 美元，Benzinga 报道。该公司目前对该股票给予 “增持” 评级。华尔街分析师的目标价格暗示该股票当前价格有 27.81% 的潜在上涨空间。</p>
<ul>
<li>当前值得关注的顶级分析师评级医疗股票</li>
</ul>
<p>其他股票分析师最近也对该股票发布了报告。瑞穗证券将泰尼特保健的目标价格从 194.00 美元上调至 225.00 美元，并在 10 月 17 日的研究报告中给予该公司 “跑赢大盘” 评级。巴克莱将泰尼特保健的目标价格从 208.00 美元上调至 229.00 美元，并在 9 月 18 日的报告中给予该公司 “增持” 评级。Truist Financial 在 11 月 3 日的报告中重申了 “买入” 评级，并将泰尼特保健的目标价格设定为 240.00 美元（上调自 225.00 美元）。摩根士丹利在 10 月 29 日的研究报告中将泰尼特保健的目标价格设定为 232.00 美元，并给予该股票 “增持” 评级。最后，KeyCorp 在 10 月 8 日的报告中将泰尼特保健的目标价格从 205.00 美元上调至 225.00 美元，并给予该股票 “增持” 评级。一位股票研究分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 227.13 美元。</p>
<p>获取 <strong>泰尼特保健</strong> 的提醒：</p>
<p><strong>查看我们关于泰尼特保健的最新研究报告</strong></p>
<h2>泰尼特保健价格表现</h2>
<ul>
<li>3 家低调的医疗公司</li>
</ul>
<p>周四，THC 股价下跌 2.83 美元，报 197.16 美元。该股票交易量为 154,244 股，而其平均交易量为 1,415,734 股。该公司的债务与股本比率为 2.27，流动比率为 1.71，速动比率为 1.63。泰尼特保健的 12 个月低点为 109.82 美元，12 个月高点为 217.43 美元。该公司的市值为 173.3 亿美元，市盈率为 13.51，PEG 比率为 0.89，贝塔值为 1.53。该公司的 50 日移动平均线为 198.89 美元，200 日移动平均线为 177.72 美元。</p>
<p>泰尼特保健（NYSE:THC - 获取免费报告）最近在 10 月 28 日发布了其财报。该公司报告季度每股收益为 3.70 美元，超出分析师一致预期的 3.33 美元，超出幅度为 0.37 美元。泰尼特保健的净利润率为 6.49%，股本回报率为 25.11%。该公司季度收入为 52.9 亿美元，而分析师预期为 52.6 亿美元。去年同期，该公司的每股收益为 2.93 美元。该公司的季度收入同比增长 3.2%。泰尼特保健已将其 2025 财年的指导目标设定为 15.930-16.26 每股收益。卖方分析师预测，泰尼特保健在当前财年将发布 12.24 每股收益。</p>
<h2>内部人士下注</h2>
<ul>
<li>HCA Healthcare：短期挫折，长期实力</li>
</ul>
<p>在其他泰尼特保健的新闻中，董事理查德·W·费舍尔在 10 月 29 日的交易中出售了 2,500 股该公司的股票。股票以平均价格 208.43 美元出售，总价值为 521,075.00 美元。交易完成后，该董事持有 8,792 股公司股票，价值 1,832,516.56 美元。该交易使其持股减少了 22.14%。该交易已在证券交易委员会的备案中披露，相关信息可在此链接查看。此外，首席执行官 Saumya Sutaria 在 9 月 10 日的交易中出售了 78,762 股该公司的股票。股票以平均价格 190.78 美元出售，总价值为 15,026,214.36 美元。交易完成后，首席执行官直接持有 368,683 股公司股票，价值约 70,337,342.74 美元。这代表其持股减少了 17.60%。该销售的披露信息可在 SEC 备案中查看。在过去三个月中，内部人士共出售了 134,044 股公司股票，价值 25,977,997 美元。公司内部人士持有公司股票的 0.81%。</p>
<h2>泰尼特保健的机构交易</h2>
<p>几家对冲基金和其他机构投资者最近也买卖了该股票的股份。AlphaQuest LLC 在第二季度将其在泰尼特保健的股份增加了 230.8%。AlphaQuest LLC 现在拥有 1,763 股公司股票，价值 310,000 美元，此前在该期间内又购买了 1,230 股。加拿大皇家银行在第一季度将其在泰尼特保健的持仓增加了 34.0%。加拿大皇家银行现在拥有 119,349 股公司股票，价值 16,052,000 美元，此前在该期间内又购买了 30,281 股。Leith Wheeler Investment Counsel Ltd.在第二季度将其在泰尼特保健的持仓增加了 22.2%。Leith Wheeler Investment Counsel Ltd.现在拥有 82,813 股公司股票，价值 14,575,000 美元，此前在该期间内又购买了 15,019 股。Cullen Frost Bankers Inc.在第二季度将其在泰尼特保健的持仓增加了 46.6%。Cullen Frost Bankers Inc.现在拥有 601 股公司股票，价值 106,000 美元，此前在该期间内又购买了 191 股。最后，瑞银资产管理美洲有限公司的一个独立业务单位在第一季度将其在泰尼特保健的股份增加了 4.9%。瑞银资产管理美洲有限公司的一个独立业务单位现在拥有 276,969 股公司股票，价值 37,252,000 美元，此前在上个季度又购买了 12,914 股。机构投资者持有公司股票的 95.44%。</p>
<h2>关于泰尼特保健</h2>
<p>（获取免费报告）</p>
<p>泰尼特保健公司在美国作为一家多元化的医疗服务公司运营。该公司通过两个部门运营：医院运营与服务，以及门诊护理。其综合医院提供急性护理服务、手术和恢复室、放射学和呼吸治疗服务、临床实验室和药房。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们认为比泰尼特保健更好的股票</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>AMD 到 300 美元看起来很容易——这里是为什么 500 美元可能是下一个</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>超过 50 亿美元的回购：DraftKings、AppLovin 和 Altria 在告诉你什么</li>
<li>黄金交叉股票：模式、示例和图表</li>
<li>4 只高收益房地产股票，投资者开始防御性投资时购买</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在泰尼特保健吗？</h2>
<p>在考虑泰尼特保健之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而泰尼特保健并不在名单上。</p>
<p>虽然泰尼特保健目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

泰尼特保健

<p>富国银行将泰尼特保健的目标价格从 238.00 美元上调至 252.00 美元，维持 “增持” 评级，暗示潜在上涨幅度为 27.81%。其他分析师也提高了他们的目标价格，普遍给予 “适度买入” 评级，平均目标价格为 227.13 美元。泰尼特保健最近的财报超出预期，内部人士则在出售股票。该股交易价格为 197.16 美元，市值为 173.3 亿美元</p>

<p>Tenet Healthcare (NYSE:THC - Get Free Report) had its price objective boosted by equities research analysts at Wells Fargo &amp; Company from $238.00 to $252.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an &#34;overweight&#34; rating on the stock. Wells Fargo &amp; Company's price target would suggest a potential upside of 27.81% from the stock's current price.</p>
<div class="lb-trans"><p>泰尼特保健（NYSE:THC - 获取免费报告）在周四发布给客户和投资者的研究报告中，华尔街分析师将其目标价格从 238.00 美元上调至 252.00 美元，Benzinga 报道。该公司目前对该股票给予 “增持” 评级。华尔街分析师的目标价格暗示该股票当前价格有 27.81% 的潜在上涨空间。</p>
</div><ul>
<li>Top Analyst-Rated Healthcare Stocks to Watch Now</li>
</ul>
<div class="lb-trans"><ul>
<li>当前值得关注的顶级分析师评级医疗股票</li>
</ul>
</div><p>Other equities analysts have also recently issued reports about the stock. Mizuho upped their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 17th. Barclays boosted their price objective on Tenet Healthcare from $208.00 to $229.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, September 18th. Truist Financial reaffirmed a &#34;buy&#34; rating and set a $240.00 price objective (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Morgan Stanley set a $232.00 target price on Tenet Healthcare and gave the stock an &#34;overweight&#34; rating in a research note on Wednesday, October 29th. Finally, KeyCorp lifted their price objective on Tenet Healthcare from $205.00 to $225.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $227.13.</p>
<div class="lb-trans"><p>其他股票分析师最近也对该股票发布了报告。瑞穗证券将泰尼特保健的目标价格从 194.00 美元上调至 225.00 美元，并在 10 月 17 日的研究报告中给予该公司 “跑赢大盘” 评级。巴克莱将泰尼特保健的目标价格从 208.00 美元上调至 229.00 美元，并在 9 月 18 日的报告中给予该公司 “增持” 评级。Truist Financial 在 11 月 3 日的报告中重申了 “买入” 评级，并将泰尼特保健的目标价格设定为 240.00 美元（上调自 225.00 美元）。摩根士丹利在 10 月 29 日的研究报告中将泰尼特保健的目标价格设定为 232.00 美元，并给予该股票 “增持” 评级。最后，KeyCorp 在 10 月 8 日的报告中将泰尼特保健的目标价格从 205.00 美元上调至 225.00 美元，并给予该股票 “增持” 评级。一位股票研究分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，四位分析师给予 “持有” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “适度买入”，平均目标价格为 227.13 美元。</p>
</div><p>Get <strong>Tenet Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>泰尼特保健</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Research Report on Tenet Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们关于泰尼特保健的最新研究报告</strong></p>
</div><h2>Tenet Healthcare Price Performance</h2>
<div class="lb-trans"><h2>泰尼特保健价格表现</h2>
</div><ul>
<li>3 Under-the-Radar Healthcare Companies</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家低调的医疗公司</li>
</ul>
</div><p>THC traded down $2.83 on Thursday, hitting $197.16. 154,244 shares of the stock were exchanged, compared to its average volume of 1,415,734. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. Tenet Healthcare has a 12 month low of $109.82 and a 12 month high of $217.43. The firm has a market capitalization of $17.33 billion, a price-to-earnings ratio of 13.51, a PEG ratio of 0.89 and a beta of 1.53. The business has a 50-day moving average of $198.89 and a two-hundred day moving average of $177.72.</p>
<div class="lb-trans"><p>周四，THC 股价下跌 2.83 美元，报 197.16 美元。该股票交易量为 154,244 股，而其平均交易量为 1,415,734 股。该公司的债务与股本比率为 2.27，流动比率为 1.71，速动比率为 1.63。泰尼特保健的 12 个月低点为 109.82 美元，12 个月高点为 217.43 美元。该公司的市值为 173.3 亿美元，市盈率为 13.51，PEG 比率为 0.89，贝塔值为 1.53。该公司的 50 日移动平均线为 198.89 美元，200 日移动平均线为 177.72 美元。</p>
</div><p>Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts' consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same quarter last year, the business posted $2.93 earnings per share. The company's quarterly revenue was up 3.2% on a year-over-year basis. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Sell-side analysts forecast that Tenet Healthcare will post 12.24 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>泰尼特保健（NYSE:THC - 获取免费报告）最近在 10 月 28 日发布了其财报。该公司报告季度每股收益为 3.70 美元，超出分析师一致预期的 3.33 美元，超出幅度为 0.37 美元。泰尼特保健的净利润率为 6.49%，股本回报率为 25.11%。该公司季度收入为 52.9 亿美元，而分析师预期为 52.6 亿美元。去年同期，该公司的每股收益为 2.93 美元。该公司的季度收入同比增长 3.2%。泰尼特保健已将其 2025 财年的指导目标设定为 15.930-16.26 每股收益。卖方分析师预测，泰尼特保健在当前财年将发布 12.24 每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>HCA Healthcare: Temporary Setbacks, Long-Term Strength</li>
</ul>
<div class="lb-trans"><ul>
<li>HCA Healthcare：短期挫折，长期实力</li>
</ul>
</div><p>In other Tenet Healthcare news, Director Richard W. Fisher sold 2,500 shares of the business's stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the transaction, the director owned 8,792 shares of the company's stock, valued at $1,832,516.56. The trade was a 22.14% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, CEO Saumya Sutaria sold 78,762 shares of the firm's stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $190.78, for a total value of $15,026,214.36. Following the transaction, the chief executive officer directly owned 368,683 shares in the company, valued at approximately $70,337,342.74. This represents a 17.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 134,044 shares of company stock valued at $25,977,997 over the last three months. Corporate insiders own 0.81% of the company's stock.</p>
<div class="lb-trans"><p>在其他泰尼特保健的新闻中，董事理查德·W·费舍尔在 10 月 29 日的交易中出售了 2,500 股该公司的股票。股票以平均价格 208.43 美元出售，总价值为 521,075.00 美元。交易完成后，该董事持有 8,792 股公司股票，价值 1,832,516.56 美元。该交易使其持股减少了 22.14%。该交易已在证券交易委员会的备案中披露，相关信息可在此链接查看。此外，首席执行官 Saumya Sutaria 在 9 月 10 日的交易中出售了 78,762 股该公司的股票。股票以平均价格 190.78 美元出售，总价值为 15,026,214.36 美元。交易完成后，首席执行官直接持有 368,683 股公司股票，价值约 70,337,342.74 美元。这代表其持股减少了 17.60%。该销售的披露信息可在 SEC 备案中查看。在过去三个月中，内部人士共出售了 134,044 股公司股票，价值 25,977,997 美元。公司内部人士持有公司股票的 0.81%。</p>
</div><h2>Institutional Trading of Tenet Healthcare</h2>
<div class="lb-trans"><h2>泰尼特保健的机构交易</h2>
</div><p>Several hedge funds and other institutional investors have recently bought and sold shares of the stock. AlphaQuest LLC increased its stake in shares of Tenet Healthcare by 230.8% during the second quarter. AlphaQuest LLC now owns 1,763 shares of the company's stock valued at $310,000 after buying an additional 1,230 shares during the period. Royal Bank of Canada increased its position in Tenet Healthcare by 34.0% during the 1st quarter. Royal Bank of Canada now owns 119,349 shares of the company's stock valued at $16,052,000 after purchasing an additional 30,281 shares during the period. Leith Wheeler Investment Counsel Ltd. lifted its position in shares of Tenet Healthcare by 22.2% in the 2nd quarter. Leith Wheeler Investment Counsel Ltd. now owns 82,813 shares of the company's stock worth $14,575,000 after purchasing an additional 15,019 shares during the period. Cullen Frost Bankers Inc. increased its position in shares of Tenet Healthcare by 46.6% during the second quarter. Cullen Frost Bankers Inc. now owns 601 shares of the company's stock valued at $106,000 after buying an additional 191 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Tenet Healthcare by 4.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 276,969 shares of the company's stock worth $37,252,000 after buying an additional 12,914 shares in the last quarter. Institutional investors own 95.44% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近也买卖了该股票的股份。AlphaQuest LLC 在第二季度将其在泰尼特保健的股份增加了 230.8%。AlphaQuest LLC 现在拥有 1,763 股公司股票，价值 310,000 美元，此前在该期间内又购买了 1,230 股。加拿大皇家银行在第一季度将其在泰尼特保健的持仓增加了 34.0%。加拿大皇家银行现在拥有 119,349 股公司股票，价值 16,052,000 美元，此前在该期间内又购买了 30,281 股。Leith Wheeler Investment Counsel Ltd.在第二季度将其在泰尼特保健的持仓增加了 22.2%。Leith Wheeler Investment Counsel Ltd.现在拥有 82,813 股公司股票，价值 14,575,000 美元，此前在该期间内又购买了 15,019 股。Cullen Frost Bankers Inc.在第二季度将其在泰尼特保健的持仓增加了 46.6%。Cullen Frost Bankers Inc.现在拥有 601 股公司股票，价值 106,000 美元，此前在该期间内又购买了 191 股。最后，瑞银资产管理美洲有限公司的一个独立业务单位在第一季度将其在泰尼特保健的股份增加了 4.9%。瑞银资产管理美洲有限公司的一个独立业务单位现在拥有 276,969 股公司股票，价值 37,252,000 美元，此前在上个季度又购买了 12,914 股。机构投资者持有公司股票的 95.44%。</p>
</div><h2>About Tenet Healthcare</h2>
<div class="lb-trans"><h2>关于泰尼特保健</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.</p>
<div class="lb-trans"><p>泰尼特保健公司在美国作为一家多元化的医疗服务公司运营。该公司通过两个部门运营：医院运营与服务，以及门诊护理。其综合医院提供急性护理服务、手术和恢复室、放射学和呼吸治疗服务、临床实验室和药房。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Tenet Healthcare</li>
<li>What is a Low P/E Ratio and What Does it Tell Investors?</li>
<li>AMD to $300 Looks Easy—Here’s Why $500 Could Be Next</li>
<li>What is MarketRank™? How to Use it</li>
<li>$5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You</li>
<li>Golden Cross Stocks: Pattern, Examples and Charts</li>
<li>4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比泰尼特保健更好的股票</li>
<li>什么是低市盈率，它对投资者意味着什么？</li>
<li>AMD 到 300 美元看起来很容易——这里是为什么 500 美元可能是下一个</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>超过 50 亿美元的回购：DraftKings、AppLovin 和 Altria 在告诉你什么</li>
<li>黄金交叉股票：模式、示例和图表</li>
<li>4 只高收益房地产股票，投资者开始防御性投资时购买</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=THC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tenet Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在泰尼特保健吗？</h2>
</div><p>Before you consider Tenet Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑泰尼特保健之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而泰尼特保健并不在名单上。</p>
</div><p>While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然泰尼特保健目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

富国银行的分析师表示，泰尼特保健（NYSE:THC）的股价预计将会上涨